Columbia University Irving Medical Center, New York, New York.
Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Canada.
JAMA Netw Open. 2024 Aug 1;7(8):e2427441. doi: 10.1001/jamanetworkopen.2024.27441.
Few studies have investigated whether the associations between pregnancy-related factors and breast cancer (BC) risk differ by underlying BC susceptibility. Evidence regarding variation in BC risk is critical to understanding BC causes and for developing effective risk-based screening guidelines.
To examine the association between pregnancy-related factors and BC risk, including modification by a of BC where scores are based on age and BC family history.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study included participants from the prospective Family Study Cohort (ProF-SC), which includes the 6 sites of the Breast Cancer Family Registry (US, Canada, and Australia) and the Kathleen Cuningham Foundation Consortium (Australia). Analyses were performed in a cohort of women enrolled from 1992 to 2011 without any personal history of BC who were followed up through 2017 with a median (range) follow-up of 10 (1-23) years. Data were analyzed from March 1992 to March 2017.
Parity, number of full-term pregnancies (FTP), age at first FTP, years since last FTP, and breastfeeding.
BC diagnoses were obtained through self-report or report by a first-degree relative and confirmed through pathology and data linkages. Cox proportional hazards regression models estimated hazard ratios (HR) and 95% CIs for each exposure, examining modification by PARS of BC. Differences were assessed by estrogen receptor (ER) subtype.
The study included 17 274 women (mean [SD] age, 46.7 [15.1] years; 791 African American or Black participants [4.6%], 1399 Hispanic or Latinx participants [8.2%], and 13 790 White participants [80.7%]) with 943 prospectively ascertained BC cases. Compared with nulliparous women, BC risk was higher after a recent pregnancy for those women with higher PARS (last FTP 0-5 years HR for interaction, 1.53; 95% CI, 1.13-2.07; P for interaction < .001). Associations between other exposures were limited to ER-negative disease. ER-negative BC was positively associated with increasing PARS and increasing years since last FTP (P for interaction < .001) with higher risk for recent pregnancy vs nulliparous women (last FTP 0-5 years HR for interaction, 1.54; 95% CI, 1.03-2.31). ER-negative BC was positively associated with increasing PARS and being aged 20 years or older vs less than 20 years at first FTP (P for interaction = .002) and inversely associated with multiparity vs nulliparity (P for interaction = .01).
In this cohort study of women with no prior BC diagnoses, associations between pregnancy-related factors and BC risk were modified by PARS, with greater associations observed for ER-negative BC.
很少有研究调查妊娠相关因素与乳腺癌(BC)风险之间的关联是否因潜在的 BC 易感性而异。有关 BC 风险变化的证据对于了解 BC 病因和制定有效的基于风险的筛查指南至关重要。
研究妊娠相关因素与 BC 风险之间的关联,包括基于年龄和 BC 家族史的 BC 评分的修改。
设计、地点和参与者:这项队列研究包括来自前瞻性家庭研究队列(ProF-SC)的参与者,该队列包括乳腺癌家族登记处(美国、加拿大和澳大利亚)的 6 个地点和 Kathleen Cuningham 基金会联合会(澳大利亚)。在没有任何个人 BC 病史的女性中进行了分析,这些女性于 1992 年至 2011 年期间入组,中位(范围)随访时间为 10(1-23)年,直至 2017 年。数据于 1992 年 3 月至 2017 年 3 月进行分析。
生育次数、足月产次数(FTP)、首次 FTP 年龄、FTP 后年数和母乳喂养。
BC 诊断通过自我报告或一级亲属报告获得,并通过病理和数据链接确认。Cox 比例风险回归模型估计了每个暴露因素的风险比(HR)和 95%置信区间(CI),并检查了 BC 评分的修饰作用。通过雌激素受体(ER)亚型评估差异。
该研究纳入了 17274 名女性(平均[SD]年龄 46.7[15.1]岁;791 名非裔或黑人参与者[4.6%],1399 名西班牙裔或拉丁裔参与者[8.2%]和 13790 名白人参与者[80.7%]),其中 943 例前瞻性确定的 BC 病例。与未生育的女性相比,最近怀孕的女性 BC 风险更高,对于评分较高的女性(最近的 FTP 0-5 年 HR 交互作用,1.53;95%CI,1.13-2.07;交互作用的 P 值<0.001)。其他暴露因素之间的关联仅限于 ER 阴性疾病。ER 阴性 BC 与评分增加和最近 FTP 后年数增加呈正相关(交互作用的 P 值<0.001),与最近怀孕的女性相比,ER 阴性 BC 的风险更高(最近的 FTP 0-5 年 HR 交互作用,1.54;95%CI,1.03-2.31)。ER 阴性 BC 与评分增加和首次 FTP 年龄在 20 岁或以上呈正相关(交互作用的 P 值=0.002),与初次生育相比,多胎生育与 ER 阴性 BC 呈负相关(交互作用的 P 值=0.01)。
在这项对无先前 BC 诊断的女性进行的队列研究中,妊娠相关因素与 BC 风险之间的关联受 BC 评分的修饰,ER 阴性 BC 的关联更大。